Cardiac Valve Repairs Market Research Report, Forecast, Revenue, Future Outlook, Trends, Growth Analysis : Ken Research

1

• Mitral Valves Shaping Future Of Cardiac Valve
  Repairs Market Outlook Ken Research

2

• According to the study, CARDIAC VALVE
  REPAIRS-MEDICAL DEVICES PIPELINE ASSESSMENT,
  2018, for many, valve tightness can be relieved
  during a procedure called balloon valvuloplasty
  which is done as part of a cardiac
  catheterization which is less invasive than
  general surgery or open heart surgery.
  Commissurotomy is used for narrowed valves, where
  the leaflets are thickened and sometimes stuck
  together. The surgeon opens the valve by cutting
  the points where the leaflets meet. New progress
  in medical science has been improving the
  scenario considerably, evident by developments in
  treatment of ailments such as mitral
  regurgitation.
• Today, there is an immediate concern regarding
  heart diseases which are on the rise owing to
  lifestyle imbalances. There are several heart
  valve ailments, all of which reduce the
  efficiency of the heart by reducing functionality
  of the valves. Options are available today that
  can resolve valve ailments either by repair or by
  replacement. When possible it is generally best
  to repair a valve and preserve a persons own
  tissue in the heart. However, if the tissue is
  too damaged, a replacement valve may be used from
  another human heart, an animal or a manufactured
  mechanical valve.

3

• Mitral regurgitation is the most common valvular
  disease and significant severity levels of mitral
  regurgitation are found in a few people above the
  age of 65 years. There are several features of
  the mitral valve for instance, its saddle-shaped
  non calcified annulus and irregular leaflet
  geometry, that make a transcatheter approach to
  repair or replace the valve more challenging
  compared to the aortic valve. New transcatheter
  minimally invasive technologies are being
  developed to address mitral valve disease in
  patients deemed too high a risk for conventional
  open-heart surgery. Several devices are under
  investigation for mitral valve repair, targeting
  the mitral valve leaflets, chordae tendinae and
  mitral annulus. The MitraClip device is the only
  Food and Drug Administration (FDA) approved
  device to treat mitral regurgitation by targeting
  the mitral leaflets. Currently there are more
  than ten different transcatheter mitral valves
  that are in various stages of development and
  clinical trials. These transcatheter mitral
  valves can be delivered either through a
  transseptal, transapical, transaortic, or left
  atriotomy approach.

4

• Many big medical companies are exploring the
  prospects of cardiac valve treatment. US based
  Abbott Laboratories is a healthcare company that
  has recently been part of major developments in
  mitral valve treatment. In May 2018, Abbott
  announced favorable outcomes from the first
  hundred patients treated in a global study of its
  Tendyne Transcatheter Mitral Valve Replacement
  System (TMVR) system, the first and only mitral
  replacement valve that is repositionable and
  fully retrievable to allow for more precise
  implantation to improve patient outcome. This
  trial is the largest study of a transcatheter
  mitral valve replacement device to date.

5

• Cardiac valve treatment is proving to be a
  flourishing research sector with more and more
  developments taking place. Repairing cardiac
  valves is increasingly incorporating new research
  evident by the developments in treatment of
  mitral regurgitation. New devices are being
  developed and certified by reliable
  establishments such as the US based FDA and many
  more are in the making. Global giants like Abbott
  are also showing their interests in heart valve
  treatment evident by their recent research
  project on transcatheter mitral valve
  replacement.

6

• To know more, click on the link below
• https//www.kenresearch.com/healthcare/medical-dev
  ices/cardiac-valve-repairs/151018-91.html
• Related Reports-
• https//www.kenresearch.com/healthcare/medical-dev
  ices/cardiac-valve-repairs-medical-devices/72780-9
  1.html
• https//www.kenresearch.com/healthcare/medical-dev
  ices/cardiac-valve-repairs-medical-devices-2017/10
  0106-91.html
• Contact UsKen ResearchAnkur Gupta, Head
  Marketing Communicationssales_at_kenresearch.com
• 91-9015378249

7
(No Transcript)